MOLINA HEALTHCARE, INC. - COMMON STOCK (MOH)

Historical Holders from Q1 2014 to Q3 2025

Symbol
MOH on NYSE
CUSIP
60855R100
Type / Class
Equity / COMMON STOCK
Shares outstanding
54M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
56.2M
Holdings value
$10.8B
% of all portfolios
0.015%
Grand Portfolio weight change
+0.001%
Number of holders
610
Number of buys
372
Number of sells
-313
Average Value change %
+0.01%
Average buys %
+0.013%
Average sells %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of MOLINA HEALTHCARE, INC. - COMMON STOCK (MOH)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PRICE T ROWE ASSOCIATES INC /MD/ 6.5% +60% $672M $249M 3.51M +59% T. Rowe Price Associates, Inc. Sep 30, 2025
AQR CAPITAL MANAGEMENT LLC 5.41% $561M 2.93M AQR Capital Management, LLC Sep 30, 2025
Capital Research Global Investors 4% $645M 2.17M Capital Research Global Investors Jun 30, 2025

Institutional Holders of MOLINA HEALTHCARE, INC. - COMMON STOCK (MOH)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 56.2M $10.8B +$338M $191.36 610
2025 Q2 53.1M $15.8B -$61.5M $297.90 617
2025 Q1 53.2M $17.5B +$90.3M $329.39 610
2024 Q4 53.1M $15.5B -$720M $291.05 622
2024 Q3 55.2M $19B -$1.1B $344.56 605
2024 Q2 58.6M $17.4B +$701M $297.30 624
2024 Q1 56.2M $23.1B -$545M $410.83 615
2023 Q4 57.3M $20.7B +$99.8M $361.31 596
2023 Q3 56.9M $18.7B -$191M $327.89 553
2023 Q2 57.8M $17.4B +$429M $301.24 544
2023 Q1 56.5M $15.1B +$31.7M $267.49 543
2022 Q4 56.2M $18.6B +$149M $330.22 578
2022 Q3 55.7M $18.4B -$703M $329.84 550
2022 Q2 55.8M $15.6B -$92.8M $279.61 524
2022 Q1 56.2M $18.7B +$570M $333.59 520
2021 Q4 54.5M $17.3B -$296M $318.08 492
2021 Q3 55.3M $15B +$42.4M $271.31 429
2021 Q2 55.2M $14B -$49.1M $253.06 437
2021 Q1 55.4M $13B +$33.3M $233.76 420
2020 Q4 55.4M $11.8B -$359M $212.68 400
2020 Q3 57.2M $10.4B -$222M $183.04 399
2020 Q2 58.6M $10.4B -$426M $177.98 382
2020 Q1 61M $8.52B -$435M $139.71 303
2019 Q4 64M $8.68B +$495M $135.69 314
2019 Q3 60.6M $6.65B -$48.7M $109.72 320
2019 Q2 60.8M $8.7B -$218M $143.14 352
2019 Q1 62.9M $8.93B -$384M $141.96 346
2018 Q4 65.8M $7.64B -$203M $116.22 328
2018 Q3 67.2M $9.98B -$615M $148.70 333
2018 Q2 71.8M $7.04B +$145M $97.94 281
2018 Q1 70.6M $5.73B +$630M $81.18 245
2017 Q4 63.3M $4.86B +$245M $76.68 255
2017 Q3 60.4M $4.13B +$336M $68.76 227
2017 Q2 55.5M $3.84B +$192M $69.18 253
2017 Q1 53.4M $2.44B +$231M $45.60 239
2016 Q4 52.1M $2.83B +$41.1M $54.26 267
2016 Q3 51.3M $2.99B +$90M $58.32 271
2016 Q2 50.1M $2.5B -$2.5M $49.90 258
2016 Q1 49.1M $3.17B -$93M $64.49 273
2015 Q4 51.2M $3.08B +$98.1M $60.13 279
2015 Q3 49.1M $3.38B +$134M $68.85 294
2015 Q2 46.9M $3.29B +$404M $70.30 267
2015 Q1 40.7M $2.74B +$158M $67.29 229
2014 Q4 38.8M $2.08B +$92.8M $53.53 195
2014 Q3 36.9M $1.56B +$30.4M $42.30 187
2014 Q2 37.1M $1.66B +$102M $44.63 191
2014 Q1 34.7M $1.3B +$12.1M $37.56 170